BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15954382)

  • 21. Kawasaki Disease: A Condition of Many Guises.
    Yeo WS
    Ann Acad Med Singap; 2018 Sep; 47(9):388-389. PubMed ID: 30324967
    [No Abstract]   [Full Text] [Related]  

  • 22. Evidence for a superantigen mediated process in Kawasaki disease.
    Curtis N; Zheng R; Lamb JR; Levin M
    Arch Dis Child; 1995 Apr; 72(4):308-11. PubMed ID: 7763061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Kawasaki disease--two case reports].
    Mroczkowska-Juchniewicz A; Moszyńska B; Pawłowska-Kamieniak A; Szczepanowska A; Papierkowski A
    Pol Merkur Lekarski; 1997 Jul; 3(13):20-1. PubMed ID: 9432293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recommendations for intravenous immunoglobulin therapy of Kawasaki disease.
    Shulman ST
    Pediatr Infect Dis J; 1992 Nov; 11(11):985-6. PubMed ID: 1454455
    [No Abstract]   [Full Text] [Related]  

  • 25. Kawasaki disease: who is at risk?
    Newburger JW
    J Pediatr; 2000 Aug; 137(2):149-52. PubMed ID: 10931403
    [No Abstract]   [Full Text] [Related]  

  • 26. Kawasaki disease--treatment with intravenous immunoglobulin during the acute stage.
    Singh S; Kumar L
    Indian Pediatr; 1996 Aug; 33(8):689-92. PubMed ID: 8979554
    [No Abstract]   [Full Text] [Related]  

  • 27. Revisiting steroids in the primary treatment of acute Kawasaki disease.
    Burns JC
    J Pediatr; 2006 Sep; 149(3):291-2. PubMed ID: 16939734
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of Kawasaki disease.
    Newburger JW
    Lancet; 1996 Apr; 347(9009):1128. PubMed ID: 8609740
    [No Abstract]   [Full Text] [Related]  

  • 29. Kawasaki disease: diagnosis, management, and long-term implications.
    Satou GM; Giamelli J; Gewitz MH
    Cardiol Rev; 2007; 15(4):163-9. PubMed ID: 17575479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dengue-Triggered Kawasaki Disease: A Report of 2 Cases.
    Guleria S; Jindal AK; Pandiarajan V; Singh MP; Singh S
    J Clin Rheumatol; 2018 Oct; 24(7):401-404. PubMed ID: 29424760
    [No Abstract]   [Full Text] [Related]  

  • 31. [Mucocutaneous lymph node syndrome, Kawasaki disease. A review and report of 3 cases].
    Rasmussen NH; Pedersen IL; Thelle T; Grymer LF; Christensen MF
    Ugeskr Laeger; 1980 Sep; 142(38):2472-5. PubMed ID: 7445146
    [No Abstract]   [Full Text] [Related]  

  • 32. [Kawasaki disease].
    Shulman ST
    Bol Med Hosp Infant Mex; 1991 Jun; 48(6):383-4. PubMed ID: 1716911
    [No Abstract]   [Full Text] [Related]  

  • 33. Kawasaki disease: update on diagnosis, treatment, and a still controversial etiology.
    Fischer P; Uttenreuther-Fischer MM; Naoe S; Gaedicke G
    Pediatr Hematol Oncol; 1996; 13(6):487-501. PubMed ID: 8940732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New therapeutic aspects in Kawasaki syndrome and personal experiences].
    Neudorf U
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():137-9. PubMed ID: 8499743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kawasaki disease and scald injuries: a possible association.
    Wong D; Nutting A; Yeung RS; McCrindle BW
    Can J Cardiol; 2004 Sep; 20(11):1147-9. PubMed ID: 15457311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nerve growth factor circulating levels are increased in Kawasaki disease: correlation with disease activity and reduced angiotensin converting enzyme levels.
    Falcini F; Cerinic MM; Ermini M; Generini S; Lombardi A; Pignone A; Leoncini G; Tirassa P; Aloe L
    J Rheumatol; 1996 Oct; 23(10):1798-802. PubMed ID: 8895162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of angiogenic genes to the complex genetic trait underlying Kawasaki disease.
    Thornton S
    Arthritis Rheum; 2006 May; 54(5):1361-5. PubMed ID: 16645964
    [No Abstract]   [Full Text] [Related]  

  • 38. Kawasaki syndrome.
    Wortmann DW
    Semin Dermatol; 1992 Mar; 11(1):37-47. PubMed ID: 1550715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kawasaki syndrome: immunomodulatory benefit and potential toxin neutralization by intravenous immune globulin.
    Leung DY
    Clin Exp Immunol; 1996 May; 104 Suppl 1():49-54. PubMed ID: 8625544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical and therapeutic aspects of Kawasaki disease. Clinical contribution].
    Massimo L; Di Luna F; Sottile R; Fidelini N; Alvano L; De Vita L
    Pediatr Med Chir; 1987; 9(5):613-8. PubMed ID: 3441437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.